June 8, 2008
LOS ANGELES, June 6, 2008 – KYTHERA Biopharmaceuticals, Inc. ("Kythera") announced today its participation in the private company forum at the 29th Annual Goldman Sachs Global Healthcare Conference on Monday, June 9, 2008 from 4:45 to 6:15 p.m. PST in Salons 3 and 4 at The Ritz-Carlton Laguna Nigel in Dana Point, CA. This event marks Kythera’s second appearance at the Goldman Sachs Private Company Forum. The Company previously participated in 2007.
“We are very excited to be participating in the Goldman Sachs Global Healthcare Conference for a second year,” said Keith Leonard, President and CEO. “We view this as an acknowledgement of KYTHERA’s progress as a private company.”
Kythera announced in May the close of $40 Million Series C Financing led by JAFCO Co. Ltd. Kythera plans to use the proceeds of this financing to complete Phase 2 trials for its lead product, ATX-101, an adipolytic agent being studied for minimally-invasive reduction of localized fat deposits.
Keith Leonard, President and Chief Executive Officer, Patty Walker, MD, Chief Medical Officer, Amit Munshi, Chief Business Officer and John Smither, Chief Financial Officer, will be available to discuss the Company during the forum. The conference will be held June 9-12, 2008 at The Ritz-Carlton Laguna Nigel in Dana Point, CA.